A number of companies are expected to report their earnings for the second quarter including US Airways Group Inc (NYSE:LCC), WellPoint, Inc. (NYSE:WLP), Wyndham Worldwide Corporation (NYSE:WYN), GlaxoSmithKline plc (NYSE:GSK), and Akamai Technologies, Inc. (NYSE:AKAM) on Wednesday, July 24, 2013.
Earnings Preview
US Airways Group Inc (NYSE:LCC)
Wall Street analysts expect US Airways Group Inc (NYSE:LCC) to report $1.51 earnings per share, lower than its earnings of $1.61 per share in the same period last year. During the first quarter, the airlines company posted earnings of $0.31 per share. Its revenue is projected to be around $3.84 billion, slightly lower than its $3.75 billion revenue in the same period a year earlier.
For the full fiscal 2013, US Airways Group Inc (NYSE:LCC) is projected to deliver $3.00 earnings per share and $14.39 billion revenue. Last year, the airlines company reported $2.79 earnings per share and $13.8 billion revenue.
WellPoint, Inc. (NYSE:WLP)
Base on the average estimates of Wall Street analysts, WellPoint, Inc. (NYSE:WLP)’s earnings per share is expected to increase by 3.4 percent and its revenue by 17.6 percent compared with its financial results in the same period a year ago. Analysts estimated that the company will post $2.11 earnings per share and $17.84 billion revenue for the second quarter this year.
For the full fiscal 2013, WellPoint, Inc. (NYSE:WLP) is projected to achieve an earnings of $8.03 per share and $71.34 billion revenue. Last year, the company reported $7.56 EPS and $6.73 billion revenue.
Wyndham Worldwide Corporation (WYN)
Analysts anticipated that Wyndham Worldwide Corporation (NYSE:WYN) will report higher financial results for the second quarter this year compared with its earnings results in the same period a year ago. Its earnings per share are estimated to increase by 4.6 percent to $0.91 from $0.87. Its revenue is projected to be around $1.24 billion, higher by 8.5 percent from $1.14 billion.
For the entire 2013, Wyndham Worldwide Corporation (NYSE:WYN) is expected to generate $3.71 earnings per share and $4.95 billion revenue compared with its $3.29 EPS and $4.53 billion revenue in 2012.
GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc (NYSE:GSK) recently stated that some of its executives in its business operations in China may have violated laws in the country for allegedly committing bribery and corruption to boost sales. Argus Research Co. analyst, John Eade opined that the problem could be a headline risk, but not an operational risk for the company.
On the other hand, Damien Conover of Morningstar said that the situation could have a long-term impact on the shares of GlaxoSmithKline if China will implement severe actions, but a lesser disciplinary action will reduce the sales of the company, but not permanent. In other words, the impact to its financial performance could be minimal.
GlaxoSmithKline plc (NYSE:GSK) is expected to achieve $3.93 earnings per share and $40.58 billion revenue for the fiscal 2013. Wall Street analysts did not issue an EPS and revenue estimate for the company for the second quarter.
Akamai Technologies, Inc. (AKAM)
Akamai Technologies, Inc. (NASDAQ:AKAM) is expected to report better financial results for the second quarter compared with its earnings results a year ago. Analysts projected that its earnings per share will rise by 7 percent to $0.46 and revenue will increase by 13 percent to $374.4 million.
For the fiscal 2013, analysts estimated that Akamai Technologies, Inc. (NYSE:AKAM) $1.95 EPS and $1.54 billion revenue compared with its $1.60 EPS and $1.37 billion revenue last year.
